Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Pruritus Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Pruritus Therapeutics Market, by Drug Type, 2019-2029 (USD Billion)
1.2.3. Pruritus Therapeutics Market, by Disease Type, 2019-2029 (USD Billion)
1.2.4. Pruritus Therapeutics Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Pruritus Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Pruritus Therapeutics Market Dynamics
3.1. Pruritus Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of skin diseases worldwide
3.1.1.2. Growing emergence of e-pharmacy
3.1.1.3. Strategic initiatives from leading market players
3.1.2. Market Challenges
3.1.2.1. Lack of awareness towards underlying disease
3.1.3. Market Opportunities
3.1.3.1. Growing healthcare infrastructure in developing regions
3.1.3.2. Rising number of geriatric individuals
Chapter 4. Global Pruritus Therapeutics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Pruritus Therapeutics Market, by Drug Type
6.1. Market Snapshot
6.2. Global Pruritus Therapeutics Market by Drug Type, Performance - Potential Analysis
6.3. Global Pruritus Therapeutics Market Estimates & Forecasts by Drug Type 2019-2029 (USD Billion)
6.4. Pruritus Therapeutics Market, Sub Segment Analysis
6.4.1. Corticosteroids
6.4.2. Antihistamines
6.4.3. Local Anesthetics
6.4.4. Immunosuppressant
6.4.5. Others
Chapter 7. Global Pruritus Therapeutics Market, by Disease Type
7.1. Market Snapshot
7.2. Global Pruritus Therapeutics Market by Disease Type, Performance - Potential Analysis
7.3. Global Pruritus Therapeutics Market Estimates & Forecasts by Disease Type 2019-2029 (USD Billion)
7.4. Pruritus Therapeutics Market, Sub Segment Analysis
7.4.1. Atopic Dermatitis
7.4.2. Allergic Contact Dermatitis
7.4.3. Urticaria
7.4.4. Others
Chapter 8. Global Pruritus Therapeutics Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Pruritus Therapeutics Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Pruritus Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
8.4. Pruritus Therapeutics Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Drug stores & Retail Pharmacies
8.4.3. Online providers
Chapter 9. Global Pruritus Therapeutics Market, Regional Analysis
9.1. Pruritus Therapeutics Market, Regional Market Snapshot
9.2. North America Pruritus Therapeutics Market
9.2.1. U.S. Pruritus Therapeutics Market
9.2.1.1. Drug Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Disease Type breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Pruritus Therapeutics Market
9.3. Europe Pruritus Therapeutics Market Snapshot
9.3.1. U.K. Pruritus Therapeutics Market
9.3.2. Germany Pruritus Therapeutics Market
9.3.3. France Pruritus Therapeutics Market
9.3.4. Spain Pruritus Therapeutics Market
9.3.5. Italy Pruritus Therapeutics Market
9.3.6. Rest of Europe Pruritus Therapeutics Market
9.4. Asia-Pacific Pruritus Therapeutics Market Snapshot
9.4.1. China Pruritus Therapeutics Market
9.4.2. India Pruritus Therapeutics Market
9.4.3. Japan Pruritus Therapeutics Market
9.4.4. Australia Pruritus Therapeutics Market
9.4.5. South Korea Pruritus Therapeutics Market
9.4.6. Rest of Asia Pacific Pruritus Therapeutics Market
9.5. Latin America Pruritus Therapeutics Market Snapshot
9.5.1. Brazil Pruritus Therapeutics Market
9.5.2. Mexico Pruritus Therapeutics Market
9.5.3. Rest of Latin America Pruritus Therapeutics Market
9.6. Rest of The World Pruritus Therapeutics Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. AbbVie Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Amgen Inc.
10.2.3. Bausch Health Companies Inc.
10.2.4. Cara therapeutics, Inc.
10.2.5. Cipla Ltd.
10.2.6. Eilly Lilly and company
10.2.7. Evelo Biosciences
10.2.8. Galderma S.A.
10.2.9. LEO Pharma
10.2.10. MC2 therapeuitics
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption